NewsTrending topic
Modified Vitamin B12 Compound Shows Early Promise Against Glioblastoma in Lab Studies
A viral post claims a modified vitamin B12 compound could help treat glioblastoma. The underlying science is real early-stage lab research — here's what it actually shows, and what it doesn't.
Original commentary from the Cancer Explained editorial team.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
“Researchers have developed a modified vitamin B12 compound, nitrosylcobalamin (NO-Cbl), that releases nitric oxide directly into tumor cells.”
Nothing has loaded from Instagram. We do not connect you to Meta unless you ask, because that would let them set cookies through this page. Open it on Instagram instead.
A post from the Instagram account jerryscience talks about a modified vitamin B12 compound. Researchers call it nitrosylcobalamin (NO-Cbl). It's built to release nitric oxide right into tumor cells. The post says it shows promise against glioblastoma, the most severe form of brain cancer.
What the science actually says
Nitrosylcobalamin is a real, published area of lab research. It wasn't invented for social media. Vitamin B12 (cobalamin) gets taken up fast by fast-dividing cells, including many cancer cells. So researchers tried attaching a nitric-oxide-releasing group to a B12 molecule. The idea: sneak a tumor-damaging payload into cancer cells that soak up a lot of B12 — including some glioblastoma cell lines. Nitric oxide can trigger cell death and disrupt cancer cell signals at the doses studied.
This work has produced lab findings — in cell culture and animal models — that hint the compound can slow tumor growth. That includes use alongside other treatments. That's a genuinely interesting lead. But it's still an early-stage lab finding. It is not a treatment you can get as a patient. It hasn't been tested in human trials for glioblastoma as of this writing.
What this post gets right and wrong
The post describes a real research idea. It also notes this was an early lab study that needs more testing. That's a fair way to frame early science. The risk shows up further down the share chain — as "vitamin B12 treats brain cancer." That's not what the research shows. Glioblastoma stays one of the hardest cancers to treat. Going from a promising lab compound to an approved drug usually takes many years and several trial phases, if it works out at all.
What to do with this information
There's no reason to avoid or fear vitamin B12 because of this research. This isn't the vitamin in its normal form. It's a chemically modified version, studied only in a lab. If you or your family face a glioblastoma diagnosis, lean on your oncology team for treatment choices. You can ask about clinical trial options through tools like the National Cancer Institute's clinical trials database if you want to track emerging research.
How this article was prepared
An AI-assisted editorial system helped prepare this page based on published descriptions of nitrosylcobalamin research and the original social media post. No named medical reviewer has reviewed it unless one is listed.
Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to glioblastoma. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.